Updated: March 25, 2020 05:16 PM
Created: March 25, 2020 01:48 PM
ROCHESTER, N.Y. (WHEC) -- The University of Rochester Medical Center is participating in a National Institutes of Health-sponsored clinical trial to evaluate the safety and effectiveness of the drug remdesivir in hospitalized adults diagnosed with coronavirus.
The treatment has shown promise treating Ebola, MERS, and SARS.
The tests will be conducted with coronavirus patients at Strong Memorial Hospital.
The University of Rochester Medical Center is among nine locations involved in the trial.
Copyright 2020 - WHEC-TV, LLC A Hubbard Broadcasting Company